Viral hepatitis is an important problem in the United States. Routine hepatitis A cases have decreased due to vaccination, as have acute cases of Hepatitis B. Hepatitis C, however, is a larger problem in this country.

The transmission of hepatitis A occurs through fecal-oral route in locations with inadequate sanitation. Hepatitis B and C infections occur primarily through blood-to-blood transmission. Hepatitis B has potential to be spread through any body fluid and most Hepatitis B infections occur during childhood. Vaccines are available for hepatitis A and B. Children, patients with chronic liver disease, and others should be vaccinated. There is no vaccine for hepatitis C.

Only symptomatic treatment is needed for hepatitis A. Hepatitis B has many possible treatment choices. The choices for hepatitis C therapy are pegylated interferon with ribavirin. All medications have side effects and should be physician monitored.

This session will discuss the epidemiology, transmission, treatment options, and vaccines availability for treatment of hepatitis A, B, and C.

Section Description

We are pleased to present the Abstracts from the SGNA's 32nd Annual Course: Passion for GI Nursing: Pass It On!! The diversity of these topics certainly reflects the richness and breadth of our specialty. In keeping with the tradition of the Annual Course, we hope the following abstracts will encourage discussions for improving nursing practice and patient care outcomes.